Maxigen Biotech Inc. (TPE:1783)

Maxigen Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	730.77	680.65	622.12	604.43	511.98	457.69
Revenue	730.77	680.65	622.12	604.43	511.98	457.69
Revenue Growth (YoY)	20.56%	9.41%	2.93%	18.06%	11.86%	1.21%
Cost of Revenue	209.96	197.33	198.02	230.44	250.95	243.17
Gross Profit	520.82	483.33	424.09	373.99	261.03	214.52
Selling, General & Admin	189.94	176.98	205.45	141.03	92.38	84.36
Research & Development	122.78	111.97	68.6	99.63	75.68	69.15
Operating Expenses	314.22	303.42	274.24	245.38	171.08	153.42
Operating Income	206.6	179.91	149.85	128.62	89.95	61.11
Interest Expense	-	-	-	-0.07	-0.2	-0.25
Interest & Investment Income	26.7	27.43	25.02	3.18	0.48	0.78
Currency Exchange Gain (Loss)	11.05	17.14	4	31.69	-3.6	-5.52
Other Non Operating Income (Expenses)	1.72	1.05	0.66	1.08	10.84	20.62
EBT Excluding Unusual Items	246.07	225.53	179.53	164.5	97.47	76.74
Gain (Loss) on Sale of Assets	0.02	0.02	13.62	1.03	-	-
Other Unusual Items	-	-	-	0.26	-	-
Pretax Income	246.09	225.55	193.14	165.78	97.47	76.74
Income Tax Expense	37.25	35.38	27.31	26.38	9.8	13.43
Net Income	208.84	190.17	165.83	139.4	87.67	63.31
Net Income to Common	208.84	190.17	165.83	139.4	87.67	63.31
Net Income Growth	39.42%	14.68%	18.95%	59.01%	38.47%	5.32%
Shares Outstanding (Basic)	89	89	89	89	84	80
Shares Outstanding (Diluted)	90	90	89	89	85	81
Shares Change (YoY)	0.96%	0.27%	0.07%	5.78%	4.81%	-8.21%
EPS (Basic)	2.33	2.13	1.86	1.57	1.04	0.79
EPS (Diluted)	2.32	2.12	1.85	1.56	1.04	0.79
EPS Growth	38.22%	14.59%	18.59%	50.28%	31.75%	10.53%
Free Cash Flow	287.45	266.45	148.76	254.05	103.34	63.82
Free Cash Flow Per Share	3.19	2.97	1.66	2.84	1.22	0.79
Dividend Per Share	0.830	0.830	1.000	0.476	-	0.632
Dividend Growth	-17.00%	-17.00%	110.00%	-	-	-6.41%
Gross Margin	71.27%	71.01%	68.17%	61.88%	50.98%	46.87%
Operating Margin	28.27%	26.43%	24.09%	21.28%	17.57%	13.35%
Profit Margin	28.58%	27.94%	26.66%	23.06%	17.12%	13.83%
Free Cash Flow Margin	39.34%	39.15%	23.91%	42.03%	20.18%	13.94%
EBITDA	234.1	206.75	177.09	156.71	119.73	91.22
EBITDA Margin	32.03%	30.38%	28.47%	25.93%	23.39%	19.93%
D&A For EBITDA	27.5	26.85	27.24	28.09	29.79	30.11
EBIT	206.6	179.91	149.85	128.62	89.95	61.11
EBIT Margin	28.27%	26.43%	24.09%	21.28%	17.57%	13.35%
Effective Tax Rate	15.14%	15.69%	14.14%	15.91%	10.05%	17.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.